Search
/node/1731
Healthcare professionals, Clinical trials, Clinical Trials moved position.png, OUR KEY SLIT TRIALS
,
a {
color: #002559;
}
.h3-clinical-trials-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2-clinical-trials-headi
,
Our key SLIT-tablet randomised controlled trialsOur SLIT-tablets build on the legacy of subcutaneous immunotherapy, which was discovered in the early
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.clinical-trials-card-container {
display: flex;
gap: 40px;
justify-content: center;
max-width: 1200px;
margin: 10px auto 0 a
,
P05239Disease area: Allergic rhinoconjunctivitisPhase: IIIFollow-up: Single-seasonRegion: North AmericaAge group: Children and adolescentsNo. of parti
,
Tree SLIT-tabletTT-03Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: 24 weeksRegion: Environmental exposure chamber (Europe)Age group: A
,
Ragweed SLIT-tabletP05233Disease area: Allergic rhinoconjunctivitisPhase: II/IIIFollow-up: One yearRegion: North AmericaAge group: AdultsNo. of partic
,
HDM SLIT-tabletMT-02Disease area: Allergic rhinoconjunctivitis and allergic asthmaPhase: II/IIIFollow-up: One yearRegion: EuropeAge group: Adolescents
,
P003Disease area: Allergic rhinoconjunctivitisPhase: IIFollow-up: Up to 76 weeksRegion: Environmental exposure chamber (Europe)Age group: AdultsNo. of
,
Compliance with guidelinesIn compliance with industry guidelines, more information about all our clinical trials can be found via the freely public re
/node/1761
Healthcare professionals, Our data, Our data banner.png, Clinical trials
,
.h3-our-data-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2-our-data-heading {
margin: 0;
font-weight: 300;
,
Clinical trials, Learn more, Real-world evidence, Learn more, Clinical data sharing, Learn more
/sustainability/esg-environmental
Environment, banner_environment_4 (1).jpg, Sustainability
,
.h2-environment-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
padding-top: 1em;
}
,
Left, Our CO2 reduction targets have been confirmed by SBTi (Science Based Targets initiative) to be in line with what the latest climate science deems nece, Group 59@2x.png
,
In order to reach our goal of 42% CO2 reduction by 2030, a number decarbonization levers are either planned or underway:
,
@media only screen and (min-width: 1024px){
.seperate-images {
display:none;
}
}
@media only screen and (max-width: 1023.98px){
.full-image {
d
,
PollutionControlling chemicals used in the cultivation, purification and production of our medicines constitutes a crucial aspect of our operational f
,
Avoid pollution, Reduce, Restore
,
WaterWe work continuously to reduce our water usage, despite increasing our production and will be integrating water risk planning across our sites to
,
Screenshot 2024-02-07 at 13.50.03.png
,
.h3-environment-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
Biodiversity and EcosystemsFrom farm to pharmaA majority
,
Species Diversity, Minimize pesticide and fertilizer inputs, Protect native flora and fauna, Minumum soil disturbance
,
Resource use and circular economyResource inflowsWe strive to ensure that our resource inflows prioritise efficiency and renewability. For example, ou
,
Recognizing the impact of packaging materials, we are dedicated to minimizing waste of our product packaging. For example, since 2022, our allergy imm
,
At ALK, we prioritize the reduction, reuse, and recycling of waste, and promote responsible disposal practices where waste cannot be recovered.
,
Screenshot 2024-02-07 at 13.50.44.png
,
Partnering for sustainabilityThe challenges of climate change require commitments and partnerships
,
@media only screen and (min-width: 1024px){
.seperate-images {
display:none;
}
}
@media only screen and (max-width: 1023.98px){
.full-image {
d
,
.paragraphs-item-media-promo-list .field-name-field-blocks .field-items .field-item:nth-child(3) {
background-color: #67C3B7!important;
}
/sustainability
Sustainable business practices, Homepage banner photo (1).jpg, Environmental
,
.h2-sustainability-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
padding-top: 1em;
,
.h3-sustainability-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
Sustainability performanceEnvironment
,
@media only screen and (min-width: 1024px){
.double-image {
display:flex;
gap:10px;
}
.double-image .second-image-green {
width:55%;
height:100
,
,
@media only screen and (min-width: 1024px){
.double-image {
display:flex;
gap:10px;
}
.double-image .second-image-red {
width:50%;
height:100%;
,
@media only screen and (min-width: 1024px){
.double-image {
display:flex;
gap:10px;
}
.double-image .second-image-red-two {
width:55%;
height:1
,
.paragraphs-item-text { padding-top: 0 !important; }
@media only screen and (max-width:1023.98px){
.page-node-806 .paragraph--type--image-with-
,
Right, Add a subheading.png, Read more about our performance in Sustainability Report
,
<div id="sustainability_report"></div>
,
2023 Sustainability Report, Screenshot 2024-02-02 at 10.05.15.png, Read now
,
Previous sustainability reports
,
sustainability_img_1.jpeg, 2022 annual sustainability report, Download, sustainability_promo_2.jpeg, 2021 annual sustainability report, Download , sustainability_promo_3.jpeg, 2020 annual sustainability report, Download
,
.field-name-field-title {
margin-top: 2rem;
}
Partnering for sustainabilityThe challenges of climate change require commitments and partnershipsWe
,
rsz_partnering (1).png
,
ALK Alertline, Report concern, Code of Conduct, Learn more
,
Policy downloads
,
Diversity and inclusion, DOWNLOAD, Anti corruption, DOWNLOAD, Data ethics policy, DOWNLOAD, Third party code of conduct, DOWNLOAD
,
Tax policy, DOWNLOAD, Whistleblower protection policy, DOWNLOAD, UK Modern Slavery Act statement 2023, DOWNLOAD
,
setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-promo-list .field-collection-container .field-name-fi
/our-science/collaboration-and-partnerships
Collaboration & partnerships, Collaboration & partnerships banner.png
,
.h2-our-science-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
}
.h3-our-science-headi
,
.cards-collaboration {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card-coll
,
Partnering interestsAt ALK, partnerships are fundamental for our continued business development. We are fueled by commitment to innovate and continuou
,
Who to contactName: Rasmus JustTitle: Head of Global Business DevelopmentContact details: RJUDK@alk.net
const myTimeout = setTimeout(applyCSS, 800);
/our-solutions
Managing allergies, Solutions for the world's allergies, girl_with_ipad.jpeg, Consumer healthcare
,
From early intervention to treatment, Right, Many people search the internet for solutions, perhaps trying herbal treatments, traditional remedies, or symptom-suppressing medicines.They may also , our_solutions_text_image.jpeg
,
Our solutions, Consumer healthcare, Read more about our allergy solutions, Diagnostics, Read more about diagnosing allergy, Allergy vaccines, Read more about allergy immunotherapy, Emergency treatment, Read more about emergence medicine
/our-science
Our science, Our science new banner - ALK banner.png, Scientific focus
,
At the core of ALK, innovation thrives. We have spent the past 100+ years pioneering within the field of allergy with the continued purpose of helping
,
.h2-our-science-heading {
margin: 0;
font-weight: 300;
font-family: Vertigo;
font-size: 50px;
color: #0a2455;
}
.h3-our-science-headi
,
.cards {
max-width: 1200px;
display: flex;
justify-content: space-between;
gap: 30px;
}
.card {
box-shado
,
.reverse-container-text-image {
display: grid;
grid-template-columns: 1.1fr 1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-
,
.container-text-image {
display: grid;
grid-template-columns: 1fr 1.1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-column:
,
AnaphylaxisAnaphylaxis is a severe and acute allergic reaction that occurs when the immune system overreacts to a certain allergen. The health burden
,
New adjacent areasWe are founded in allergology and immunology and are leveraging our deep knowledge in ”Type 2” immune mechanisms and dysregulation w
,
Our clinical pipelineOur commitment to helping people and families living with the burden of allergy drives our discovery and development of innovativ
,
Pipeline-table-II.png
,
Read more about our scientific focus areas.
,
Clinical trialsInformation about our clinical trials can be found via the freely public registries clinicaltrialregister.eu, clinicaltrials.gov or on
/node/1766
Healthcare professionals, Real-world evidence, Real-world evidence banner.png, REWEAL
,
.h3-real-world-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2-real-world-heading {
margin: 0;
font-weight: 300, setTimeout(boxStyling, 1000);
function boxStyling() {
jQuery('.paragraphs-item-picture-promo-lis…,
Why was REWEAL initiated?, Real-world evidence img 1.png, Watch video
,
.h3-real-world-heading {
font-size: 30px;
color: #002559;
font-weight: 300;
}
.h2-real-world-heading {
margin: 0;
font-weight: 300
,
Time to REACT in AITWith the REACT-study we aim to complement existing evidence from randomised controlled trials and address some key unanswered ques
,
REACT study design, Real-world evidence img 4.png, Read infographic
,
Real-world evidence img 3.png, The REACT study, a retrospective cohort study, Go to publication, Real-world evidence img 3.png, Subgroup analyses of the REACT study, Go to publication
/contact-us
Contact information, Corporate headquarters:ALKBøge Allé 6-8DK-2970 HørsholmDenmarkE-mail: reception@alk-abello.comT (+45) 4574 7576F (+45) 4574 8690Local offices:We have , Left, Contact
,
Medical product inquiries?, If you are a patient and have inquiries related to one of ALK’s pharmaceutical products, you should always contact the prescribing doctor or other qua, Side effects, Right, Select Country
,
Reporting side effects, <p><iframe frameborder="0" allowfullscreen="" src="https://player.skyfish.com/?v=https://video.skyfish.com/ff53a1bc-, reporting_side_effects_video.jpg
,
Business Development, For matters related to business development, please contact:Rasmus JustHead of Business DevelopmentMobile: +45 41718431E-mail: RJUDK@alk.net, Got a business idea?, Left
,
Communications & Investor Relations, For matters related to Media Relations, please contact:Maiken Riise AndersenCommunications Director & Head of Media Relations,Phone: +45 50541434E-mai, Accounting information, Right
/our-science/digital-innovation
Digital innovation, ALK lab 11 - new digital innovation.png
,
@media (min-width: 1024px) {
.paragraphs-item-section-frontpage-top {
padding-top: 12%;
padding-bottom: 12%;
}
}
.h2-dig
,
.container-text-image {
display: grid;
grid-template-columns: 1fr 1.1fr;
column-gap: 6%;
}
.container-heading-subheading {
grid-column:
,
ul li::marker {
color: #0a2455;
}
.reverse-container-text-image {
display: grid;
grid-template-columns: 1.1fr 1fr;
column-gap: 6%;
}
,
Real-world impactWe are using AI and machine-learning algorithms that may improve the daily lives of people with allergy and serve to understand the g